Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer

Jeong Youp Park, Sun A. Kim, Joo Won Chung, Seungmin Bang, Seung Woo Park, Young Ki Paik, Si Young Song

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Introduction: Protein profiles of endoscopically collected pancreatic juice from normal, chronic pancreatitis patients and pancreatic cancer patients were compared to identify diagnostic biomarkers of pancreatic cancer. Methods: Secretin was injected intravenously and pancreatic juice was collected via selective cannulation of the pancreatic duct during endoscopic retrograde cholangiopancreatography. Pancreatic juices consisting of three pooled samples for normal control, chronic pancreatitis, and pancreatic cancer patients were compared using two-dimensional gel electrophoresis, and the proteins were subsequently identified using MALDI-TOF-MS. Results: Thirty-five protein spots were up-regulated twofold in pancreatic cancer compared with the levels in the normal controls, and 85 protein spots were present in pancreatic cancer samples but not in normal controls. After excluding spots that were also expressed in chronic pancreatitis, 26 protein spots that were up-regulated or only expressed in pancreatic cancer samples were identified. Among the identified proteins, we confirmed the expressions of BIG2, PRDX6, and REG1α in pancreatic cancer tissue using immunohistochemistry. ELISA showed that the serum level of REG1α was significantly higher in patients with pancreatic cancer than it was in the normal controls (P = 0.023). With the best cut-off value, the sensitivity and specificity of REG1α to differentiate normal and pancreatic cancer were 82.6 and 81.8%, compared with 69.6 and 100% for CA19-9. Conclusions: We have shown that pancreatic juice is a good source of pancreatic cancer tumor markers. Further studies are needed to determine the clinical implications of REG1α and other markers.

Original languageEnglish
Pages (from-to)1229-1238
Number of pages10
JournalJournal of cancer research and clinical oncology
Volume137
Issue number8
DOIs
Publication statusPublished - 2011 Aug 1

Fingerprint

Pancreatic Juice
Pancreatic Neoplasms
Proteomics
Biomarkers
Chronic Pancreatitis
Proteins
Secretin
Endoscopic Retrograde Cholangiopancreatography
Pancreatic Ducts
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Electrophoresis, Gel, Two-Dimensional
Tumor Biomarkers
Catheterization
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Park, Jeong Youp ; Kim, Sun A. ; Chung, Joo Won ; Bang, Seungmin ; Park, Seung Woo ; Paik, Young Ki ; Song, Si Young. / Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. In: Journal of cancer research and clinical oncology. 2011 ; Vol. 137, No. 8. pp. 1229-1238.
@article{f89e65d7eea54d6ab3ca45aa0ce50249,
title = "Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer",
abstract = "Introduction: Protein profiles of endoscopically collected pancreatic juice from normal, chronic pancreatitis patients and pancreatic cancer patients were compared to identify diagnostic biomarkers of pancreatic cancer. Methods: Secretin was injected intravenously and pancreatic juice was collected via selective cannulation of the pancreatic duct during endoscopic retrograde cholangiopancreatography. Pancreatic juices consisting of three pooled samples for normal control, chronic pancreatitis, and pancreatic cancer patients were compared using two-dimensional gel electrophoresis, and the proteins were subsequently identified using MALDI-TOF-MS. Results: Thirty-five protein spots were up-regulated twofold in pancreatic cancer compared with the levels in the normal controls, and 85 protein spots were present in pancreatic cancer samples but not in normal controls. After excluding spots that were also expressed in chronic pancreatitis, 26 protein spots that were up-regulated or only expressed in pancreatic cancer samples were identified. Among the identified proteins, we confirmed the expressions of BIG2, PRDX6, and REG1α in pancreatic cancer tissue using immunohistochemistry. ELISA showed that the serum level of REG1α was significantly higher in patients with pancreatic cancer than it was in the normal controls (P = 0.023). With the best cut-off value, the sensitivity and specificity of REG1α to differentiate normal and pancreatic cancer were 82.6 and 81.8{\%}, compared with 69.6 and 100{\%} for CA19-9. Conclusions: We have shown that pancreatic juice is a good source of pancreatic cancer tumor markers. Further studies are needed to determine the clinical implications of REG1α and other markers.",
author = "Park, {Jeong Youp} and Kim, {Sun A.} and Chung, {Joo Won} and Seungmin Bang and Park, {Seung Woo} and Paik, {Young Ki} and Song, {Si Young}",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/s00432-011-0992-2",
language = "English",
volume = "137",
pages = "1229--1238",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "8",

}

Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. / Park, Jeong Youp; Kim, Sun A.; Chung, Joo Won; Bang, Seungmin; Park, Seung Woo; Paik, Young Ki; Song, Si Young.

In: Journal of cancer research and clinical oncology, Vol. 137, No. 8, 01.08.2011, p. 1229-1238.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer

AU - Park, Jeong Youp

AU - Kim, Sun A.

AU - Chung, Joo Won

AU - Bang, Seungmin

AU - Park, Seung Woo

AU - Paik, Young Ki

AU - Song, Si Young

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Introduction: Protein profiles of endoscopically collected pancreatic juice from normal, chronic pancreatitis patients and pancreatic cancer patients were compared to identify diagnostic biomarkers of pancreatic cancer. Methods: Secretin was injected intravenously and pancreatic juice was collected via selective cannulation of the pancreatic duct during endoscopic retrograde cholangiopancreatography. Pancreatic juices consisting of three pooled samples for normal control, chronic pancreatitis, and pancreatic cancer patients were compared using two-dimensional gel electrophoresis, and the proteins were subsequently identified using MALDI-TOF-MS. Results: Thirty-five protein spots were up-regulated twofold in pancreatic cancer compared with the levels in the normal controls, and 85 protein spots were present in pancreatic cancer samples but not in normal controls. After excluding spots that were also expressed in chronic pancreatitis, 26 protein spots that were up-regulated or only expressed in pancreatic cancer samples were identified. Among the identified proteins, we confirmed the expressions of BIG2, PRDX6, and REG1α in pancreatic cancer tissue using immunohistochemistry. ELISA showed that the serum level of REG1α was significantly higher in patients with pancreatic cancer than it was in the normal controls (P = 0.023). With the best cut-off value, the sensitivity and specificity of REG1α to differentiate normal and pancreatic cancer were 82.6 and 81.8%, compared with 69.6 and 100% for CA19-9. Conclusions: We have shown that pancreatic juice is a good source of pancreatic cancer tumor markers. Further studies are needed to determine the clinical implications of REG1α and other markers.

AB - Introduction: Protein profiles of endoscopically collected pancreatic juice from normal, chronic pancreatitis patients and pancreatic cancer patients were compared to identify diagnostic biomarkers of pancreatic cancer. Methods: Secretin was injected intravenously and pancreatic juice was collected via selective cannulation of the pancreatic duct during endoscopic retrograde cholangiopancreatography. Pancreatic juices consisting of three pooled samples for normal control, chronic pancreatitis, and pancreatic cancer patients were compared using two-dimensional gel electrophoresis, and the proteins were subsequently identified using MALDI-TOF-MS. Results: Thirty-five protein spots were up-regulated twofold in pancreatic cancer compared with the levels in the normal controls, and 85 protein spots were present in pancreatic cancer samples but not in normal controls. After excluding spots that were also expressed in chronic pancreatitis, 26 protein spots that were up-regulated or only expressed in pancreatic cancer samples were identified. Among the identified proteins, we confirmed the expressions of BIG2, PRDX6, and REG1α in pancreatic cancer tissue using immunohistochemistry. ELISA showed that the serum level of REG1α was significantly higher in patients with pancreatic cancer than it was in the normal controls (P = 0.023). With the best cut-off value, the sensitivity and specificity of REG1α to differentiate normal and pancreatic cancer were 82.6 and 81.8%, compared with 69.6 and 100% for CA19-9. Conclusions: We have shown that pancreatic juice is a good source of pancreatic cancer tumor markers. Further studies are needed to determine the clinical implications of REG1α and other markers.

UR - http://www.scopus.com/inward/record.url?scp=79961166826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961166826&partnerID=8YFLogxK

U2 - 10.1007/s00432-011-0992-2

DO - 10.1007/s00432-011-0992-2

M3 - Article

C2 - 21691750

AN - SCOPUS:79961166826

VL - 137

SP - 1229

EP - 1238

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 8

ER -